
Wajd Al-Holou MD
Brain & Spinal Tumor
Assistant Professor; Co-Director of Michigan Multidisciplinary Brain Tumor Clinic; Clinical Operations Director for the Brain Tumor Program
Join to view full profile
1500 E Medical CenterAnn Arbor, MI 48109
Dr. Al-Holou is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wajd Al-Holou, based in Ann Arbor, MI, specializes in Neurosurgery, with a sub-specialty in Brain and Spinal Tumor. He completed his residency and received his medical degree from the University of Michigan, before undertaking a fellowship in Neurosurgical Oncology at the University of Texas M D Anderson Cancer Center. Since 2019, Dr. Al-Holou holds a position as an Assistant Professor at the University of Michigan Medical School. His expertise includes neurosurgical oncology, brain and spine tumors, and awake mapping. He has contributed to several publications with significant citations in reputable journals like Cancer Discovery, Cancer Cell, Lancet Oncology, Nature Medicine, and STAR protocols, pointing towards a focused research interest in the field of neuro-oncology.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2016 - 2017
University of MichiganResidency, Neurological Surgery, 2009 - 2016
University of Michigan Medical SchoolClass of 2009
Certifications & Licensure
MI State Medical License 2009 - 2028
TX State Medical License 2016 - 2018
American Board of Neurological Surgery Neurological Surgery
Publications & Presentations
PubMed
- Predicting postoperative hospice enrollment following stereotactic brain biopsy: a retrospective study and risk score development.Arushi Tripathy, Edward S Harake, Ammar Ahmad, Nora Sharba, Anran Li
Journal of Neurosurgery. 2026-10-01 - Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.Palavalasa Sravya, Leyla Nurcihan Altay, Kathy Do, Jack Freeman, Aditri Gokul
Research Square. 2026-09-18 - 1 citationsMinimizing the risks of stereotactic brain biopsy in suspected central nervous system lymphoma: a retrospective database study.Anran Li, Sara Saleh, Nora Sharba, Elnaz Guivatchian, Oren Sagher
Journal of Cancer Research and Clinical Oncology. 2026-03-26
Press Mentions
I’ve Been Diagnosed with a Brain Tumor. Now What?June 15th, 2025
Digital Twin Maps Tumor Metabolism to Guide Brain Cancer TreatmentJanuary 14th, 2026
Grant Support
- Defining Tumor Microenvironmental Interactions that drive THY1-Mediated Treatment Resistance in GlioblastomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: